WINDLAS

Windlas Biotech Share Price Windlas Biotech

₹552.9
+33.5 (6.45%)
20 April, 2024 03:40 BSE: 543329 NSE: WINDLASISIN: INE0H5O01029

Start SIP in Windlas Biotech

Start SIP

Windlas Biotech Performance

Day Range

  • Low 507
  • High 568
₹ 552

52 Week Range

  • Low 246
  • High 591
₹ 552
  • Open Price519
  • Previous Close519
  • Volume104758

Windlas Biotech Share Price

  • Over 1 Month +6.12%
  • Over 3 Month +14.88%
  • Over 6 Month +56.43%
  • Over 1 Year +120.98%

Windlas Biotech Key Statistics

P/E Ratio 21.8
PEG Ratio 1.5
Market Cap Cr 1,150
Price to Book Ratio 2.9
EPS 20.2
Dividend 0.7
Relative Strength Index 56.58
Money Flow Index 54.13
MACD Signal 4.96
Average True Range 26.14
Windlas Biotech Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 162153145141
Operating Expenses Qtr Cr 142134128124
Operating Profit Qtr Cr 20191716
Depreciation Qtr Cr 3334
Interest Qtr Cr 0000
Tax Qtr Cr 5444
Net Profit Qtr Cr 15141211
IndicatorMar 2023
Total Revenue Annual Cr 523
Operating Expenses Annual Cr 453
Operating Profit Annual in Cr 60
Depreciation Cr 12
Interest Annual Cr 1
Tax Annual Cr 14
Net Profit Annual Cr 43
IndicatorMar 2023
Cash from Operating Activity Annual Cr 61
Cash from Investing Activity Annual Cr -14
Cash from Financing Annual Activity Cr -44
Net Cash Flow Annual Cr 3
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 403
Fixed Assets Annual Cr 124
Total Non Current Assets Annual Cr 175
Total Current Assets Annual Cr 354
Total Assets Annual Cr 529
IndicatorMar 2023
Book Value Per Share Annual Rs 192
ROE Annual % 11
ROCE Annual % 14
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 14
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 162153145141
Operating Expenses Qtr Cr 142134128124
Operating Profit Qtr Cr 20191716
Depreciation Qtr Cr 3334
Interest Qtr Cr 0000
Tax Qtr Cr 5444
Net Profit Qtr Cr 15141211
IndicatorMar 2023
Total Revenue Annual Cr 523
Operating Expenses Annual Cr 453
Operating Profit Annual in Cr 60
Depreciation Cr 12
Interest Annual Cr 1
Tax Annual Cr 14
Net Profit Annual Cr 43
IndicatorMar 2023
Cash from Operating Activity Annual Cr 61
Cash from Investing Activity Annual Cr -14
Cash from Financing Annual Activity Cr -44
Net Cash Flow Annual Cr 3
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 402
Fixed Assets Annual Cr 124
Total Non Current Assets Annual Cr 175
Total Current Assets Annual Cr 354
Total Assets Annual Cr 529
IndicatorMar 2023
Book Value Per Share Annual Rs 192
ROE Annual % 11
ROCE Annual % 14
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 14

Windlas Biotech Technicals

EMA & SMA

Current Price
₹552.9
+33.5 (6.45%)
pointer
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹535.44
  • 50 Day
  • ₹521.37
  • 100 Day
  • ₹489.71
  • 200 Day
  • ₹436.29
  • 20 Day
  • ₹534.23
  • 50 Day
  • ₹526.81
  • 100 Day
  • ₹489.62
  • 200 Day
  • ₹423.93

Windlas Biotech Resistance and Support

PIVOT
₹542.49
Resistance
First Resistance 578.42
Second Resistance 603.93
Third Resistance 639.87
RSI 56.58
MFI 54.13
MACD Single Line 4.96
MACD 3.80
Support
First Resistance 516.97
Second Resistance 481.03
Third Resistance 455.52

Windlas Biotech Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 111,092 4,611,429 41.51
Week 66,678 3,005,166 45.07
1 Month 61,928 3,023,942 48.83
6 Month 178,203 6,404,631 35.94

Windlas Biotech Result Highlights

Windlas Biotech Synopsis

NSE-Medical-Ethical Drugs

Windlas Biotech belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 513.08 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2023. Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407.
Market Cap 1,154
Sales 600
Shares in Float 0.77
No of funds 15
Yield 0.76
Book Value 2.88
U/D Vol ratio 2.1
LTDebt / Equity
Alpha 0.22
Beta 0.93

Windlas Biotech

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 62.82%62.82%62.82%62.82%
Mutual Funds 10.37%10.4%10.43%10.51%
Foreign Portfolio Investors 1.18%1.35%0.8%0.8%
Financial Institutions/ Banks 0.04%0.04%0.04%
Individual Investors 21.19%21.21%21.63%22.01%
Others 4.44%4.18%4.28%3.82%

Windlas Biotech Management

Name Designation
Mr. Vivek Dhariwal Chairman & Ind.Director
Mr. Hitesh Windlass Managing Director
Mr. Manoj Kumar Windlass Joint Managing Director
Mr. Pawan Kumar Sharma Executive Director
Mr. Ashok Kumar Windlass Whole Time Director
Mrs. Prachi Jain Windlass Non Executive Director
Mr. Srinivasan Venkataraman Ind. Non-Executive Director
Mr. Gaurav Gulati Ind. Non-Executive Director

Windlas Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Windlas Biotech Corporate Action

Date Purpose Remarks
2024-02-08 Quarterly Results
2023-11-08 Quarterly Results
2023-08-08 Quarterly Results
2023-05-05 Audited Results & Final Dividend
2023-02-08 Quarterly Results

Windlas Biotech FAQs

What is Share Price of Windlas Biotech ?

Windlas Biotech share price is ₹552 As on 20 April, 2024 | 03:26

What is the Market Cap of Windlas Biotech ?

The Market Cap of Windlas Biotech is ₹1150 Cr As on 20 April, 2024 | 03:26

What is the P/E ratio of Windlas Biotech ?

The P/E ratio of Windlas Biotech is 21.8 As on 20 April, 2024 | 03:26

What is the PB ratio of Windlas Biotech ?

The PB ratio of Windlas Biotech is 2.9 As on 20 April, 2024 | 03:26

Q2FY23